Sleep Benefits From Tonsillectomy Peak at 6 Months

Title: Sleep Benefits From Tonsillectomy Peak at 6 Months
Category: Health News
Created: 7/22/2009 7:00:00 AM
Last Editorial Review: 7/22/2009 More at...

According to a nurse employed by Michael Jackson, the pop singer had repeatedly asked her to give him the powerful IV anesthetic Diprivan to treat his insomnia, even though the drug is not approved for this use. More at...

New research, conducted by Charles Wingo and his colleagues, at the University of Florida, Gainsville, suggests a link between the circadian rhythm and control of sodium (salt) levels in mice. The hormone aldosterone regulates levels of sodium in the blood and thereby helps control blood pressure. More at...

Parkinson's disease is well-known for impairing movement and causing tremors, but many patients also develop other serious problems, including sleep disturbances and significant losses in cognitive function known as dementia. Now researchers at Washington University School of Medicine in St. Louis have modeled Parkinson's-associated dementia for the first time. More at...

An online insomnia intervention based on established face-to-face cognitive behavioral therapy techniques appears to improve patients' sleep, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals. About one-third of adults report symptoms of insomnia and approximately 10 percent meet diagnostic criteria for an insomnia disorder, according to background information in the article. More at...

Mylan Inc. (NASDAQ: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug Application (ANDA) for Temazepam Capsules USP, 22.5 mg. This strength is in addition to Mylan's currently marketed 15 mg and 30 mg strengths of the product. Temazepam Capsules are the generic version of Mallinckrodt's Restoril®, a sleep aid, which had total U.S. More at...

A study in the July 1 issue of the journal SLEEP identified a distinct ECG-derived spectrographic phenotype, designated as narrow-band elevated low frequency coupling (e-LFCNB), that is associated with prevalent hypertension, stroke, greater severity of sleep disordered breathing and sleep fragmentation in patients suffering from obstructive sleep apnea (OSA). Results indicate that the odds ratio for prevalent stroke was 1.65 [CI: 1. More at...